Masked and White Coat Hypertension: Diagnosis and Management
1 point | 
50 Minutes | 
25 Jun 2024
Overview
About this course
Hypertension remains to be a global health burden. Both the American College of Cardiology / American Heart
Association (ACC/AHA) and European Society of Cardiology / European Society of Hypertension (ESC/ESH)
recognizes the need for out-of-office blood pressure monitoring to identify both white coat hypertension or
white coat syndrome, and masked hypertension. While there is no hard evidence to show long-term benefit of
treatment of white coat hypertension with hypertension-mediated organ damage (HMOD) and masked hypertension
due to methodological issues in studies, there is a recognized increased CV risk in both entities that may
need to be addressed.
This e-learning module summarizes the diagnostic approach to masked and white
coat hypertension, and reviews the data behind possible management options for these conditions.
Learning outcomes
Upon completion of the educational activity, participants should be able to
- Diagnose and manage white coat hypertension and masked hypertension
- Identify the different hypertensive-mediated organ damage (HMOD) markers
- Understand the value of out-of-office BP monitoring and hopefully integrate it into clinical practice
Speaker for this course:
Dr J.C. Mohan
Chairman, Institute of Heart and Vascular Disorders,
Jaipur Golden Hospital, New Delhi
Topics covered
- Introduction
- Diagnosing Hypertension
- Masked vs White Coat Hypertension
- To treat or not to treat: Management approach
1 CPD Point Available
- Score at least 60% on the quiz.
- A certificate can be downloaded upon successful completion. Please use the information on the certificate to claim your CPD points.
Keywords: Hypertension, masked hypertension, white coat syndrome